Search

Your search keyword '"Maria Summa"' showing total 71 results

Search Constraints

Start Over You searched for: Author "Maria Summa" Remove constraint Author: "Maria Summa"
71 results on '"Maria Summa"'

Search Results

1. Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer

2. Evaluation of a Multifunctional Polyvinylpyrrolidone/Hyaluronic Acid-Based Bilayer Film Patch with Anti-Inflammatory Properties as an Enhancer of the Wound Healing Process

3. Hydroxycinnamic Acids and Derivatives Formulations for Skin Damages and Disorders: A Review

4. Increased excitability in tat-transgenic mice: Role of tat in HIV-related neurological disorders

6. Copper nano-architecture topical cream for the accelerated recovery of burnt skin

8. The Fate of Intranasally Instilled Silver Nanoarchitectures

10. Discovery and SAR Evolution of Pyrazole Azabicyclo[3.2.1]octane Sulfonamides as a Novel Class of Non-Covalent N-Acylethanolamine-Hydrolyzing Acid Amidase (NAAA) Inhibitors for Oral Administration

11. Identification, Structure–Activity Relationship, and Biological Characterization of 2,3,4,5-Tetrahydro-1H-pyrido[4,3-b]indoles as a Novel Class of CFTR Potentiators

12. Innovative Non-PrP-Targeted Drug Strategy Designed to Enhance Prion Clearance

13. Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer

14. Biosafety and Biokinetics of Noble Metals: The Impact of Their Chemical Nature

15. Design, Synthesis, Dynamic Docking, Biochemical Characterization, and in Vivo Pharmacokinetics Studies of Novel Topoisomerase II Poisons with Promising Antiproliferative Activity

16. Keratin–cinnamon essential oil biocomposite fibrous patches for skin burn care

17. Hydroxycinnamic Acids and Derivatives Formulations for Skin Damages and Disorders: A Review

18. Electrospun polyvinylpyrrolidone (PVP) hydrogels containing hydroxycinnamic acid derivatives as potential wound dressings

19. Design, Synthesis, and Biological Evaluation of a Series of Oxazolone Carboxamides as a Novel Class of Acid Ceramidase Inhibitors

20. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor

21. Biokinetics and clearance of inhaled gold ultrasmall-in-nano architectures

22. Alginate-lavender nanofibers with antibacterial and anti-inflammatory activity to effectively promote burn healing

23. Design, Synthesis, Dynamic Docking, Biochemical Characterization, and

24. Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over β

25. Discovery of a Small Molecule Drug Candidate for Selective NKCC1 Inhibition in Brain Disorders

26. Engineering shape-defined PLGA microPlates for the sustained release of anti-inflammatory molecules

27. Dissolution test for risk assessment of nanoparticles: a pilot study

28. Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis

29. N-Acylethanolamine Acid Amidase contributes to disease progression in a mouse model of multiple sclerosis

30. Neuroinflammation in Aged Brain: Impact of the Oral Administration of Ellagic Acid Microdispersion

32. Polyvinylpyrrolidone/hyaluronic acid-based bilayer constructs for sequential delivery of cutaneous antiseptic and antibiotic

33. Combining dietary phenolic antioxidants with polyvinylpyrrolidone: Transparent biopolymer films based on: P-coumaric acid for controlled release

34. A Swath Label-Free Proteomics insight into the Faah−/− Mouse Liver

35. Hit Optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders

36. Controlled antiseptic/eosin release from chitosan-based hydrogel modified fibrous substrates

37. Activity-Based Probe for N-Acylethanolamine Acid Amidase

38. Inpatient antibiotic resistance: Everyone's problem

39. Biodegradable Ultrasmall-in-Nano Gold Architectures: Mid-Period In Vivo Distribution and Excretion Assessment

40. Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti‐inflammatory drug‐dependent gastrointestinal damage

41. NEGR1 and FGFR2 cooperatively regulate cortical development and core behaviours related to autism disorders in mice

42. Environmental training is beneficial to clinical symptoms and cortical presynaptic defects in mice suffering from experimental autoimmune encephalomyelitis

43. A biocompatible sodium alginate/povidone iodine film enhances wound healing

44. The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of Allergic Dermatitis

45. 3-Aminoazetidin-2-one Derivatives asN-Acylethanolamine Acid Amidase (NAAA) Inhibitors Suitable for Systemic Administration

46. Antibiotic stewardship: The FP's role

47. Design, Synthesis, Structure-Activity Relationship Studies, and Three-Dimensional Quantitative Structure Activity Relationship (3D-QSAR) Modeling of a Series of O-Biphenyl Carbamates as Dual Modulators of Dopamine D3 Receptor and Fatty Acid Amide Hydrolase

48. Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase

49. Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase

Catalog

Books, media, physical & digital resources